SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-20-001305
Filing Date
2020-05-22
Accepted
2020-05-22 16:10:52
Documents
2
Period of Report
2020-05-20

Document Format Files

Seq Description Document Type Size
1 form4-05222020_040537.html 4  
1 form4-05222020_040537.xml 4 4213
2 ex24-05222020_040538.htm EX-24 6915
  Complete submission text file 0001415889-20-001305.txt   12777
Mailing Address 950 WINTER STREET WALTHAM MA 02451
Business Address 950 WINTER STREET WALTHAM MA 02451 (858) 909-0749
Eloxx Pharmaceuticals, Inc. (Issuer) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address C/O ELOXX PHARMACEUTICALS, INC. 950 WINTER STREET WALTHAM MA 02451
Business Address
Seehra Jasbir (Reporting) CIK: 0001732369 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31326 | Film No.: 20905952